Zevra Therapeutics announced that it has become a Corporate Council member of the National Organization for Rare Disorders and reiterated its commitment to the rare disease community by celebrating Rare Disease Day 2023.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on KMPH:
- Zevra Therapeutics Begins Trading as ZVRA
- Zevra Therapeutics, a Rare Disease Therapeutics Company, Files Preliminary Proxy
- Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
- Zevra announces arimoclomol featured in two poster presentations
- Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th Annual WORLDSymposium™ 2023